Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)

PURPOSE: Although ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) has been established as the standard of care in patients with advanced Hodgkin lymphoma, newer regimens have been investigated, which have appeared superior in early phase II studies. Our aim was to determine if failure-fr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Gordon, Leo I., Hong, Fangxin, Fisher, Richard I., Bartlett, Nancy L., Connors, Joseph M., Gascoyne, Randy D., Wagner, Henry, Stiff, Patrick J., Cheson, Bruce D., Gospodarowicz, Mary, Advani, Ranjana, Kahl, Brad S., Friedberg, Jonathan W., Blum, Kristie A., Habermann, Thomas M., Tuscano, Joseph M., Hoppe, Richard T., Horning, Sandra J.
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2013
Sujets:
Original Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3574266/
https://ncbi.nlm.nih.gov/pubmed/23182987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.43.4803
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires